GENE ONLINE|News &
Opinion
Blog

big pharma
Merck Posts $65B in 2025 Revenue as 80 Phase 3 Programs Advance
2026-02-04
GLP-1 Drugs, Metabolic Medicine, and the $200B Weight-Loss War
2025-07-30
Big Pharma’s Next Move: BMS, Merck, Amgen Eye M&A to Tackle Patent Expirations
2024-11-14
ADC
NMT Inhibitors and Next-Gen Nectin-4 ADCs a Field Ripe for Research – Part II
2024-08-01
LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Scroll to Top